Search research articles
Contact Us
Filters
Showing results (61-70 of 108) with videos related to
Page
of 11
Sort By:
Molecules (Basel, Switzerland)
|
February 25, 2023
A Liquid Chromatography Tandem Mass Spectrometry Method for the Simultaneous Estimation of the Dopamine Receptor Antagonist LE300 and Its N-methyl Metabolite in Plasma: Application to a Pharmacokinetic Study
Mohamed M Hefnawy, Mohamed W Attwa, Adeeba A Alzamil, et al.
European Journal of Medicinal Chemistry
|
October 17, 2016
Thiadiazolodiazepine analogues as a new class of neuromuscular blocking agents: Synthesis, biological evaluation and molecular modeling study
Hussein I El-Subbagh, Adel S El-Azab, Ghada S Hassan, et al.
Bioorganic & Medicinal Chemistry
|
June 27, 2016
Design, synthesis of 2,3-disubstitued 4(3H)-quinazolinone derivatives as anti-inflammatory and analgesic agents: COX-1/2 inhibitory activities and molecular docking studies
Alaa A-M Abdel-Aziz, Laila A Abou-Zeid, Kamal Eldin H ElTahir, et al.
European Journal of Medicinal Chemistry
|
June 19, 2016
Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones
Alaa A-M Abdel-Aziz, Laila A Abou-Zeid, Kamal Eldin H ElTahir, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
December 19, 2017
Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study
Magda A-A El-Sayed, Walaa M El-Husseiny, Naglaa I Abdel-Aziz, et al.
European Journal of Medicinal Chemistry
|
September 15, 2018
Structural alterations based on naproxen scaffold: Synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking
Walaa M El-Husseiny, Magda A-A El-Sayed, Naglaa I Abdel-Aziz, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 26, 2025
Synthesis, Antitumor Activities, and Apoptosis-Inducing Activities of Schiff's Bases Incorporating Imidazolidine-2,4-dione Scaffold: Molecular Docking Studies and Enzymatic Inhibition Activities
Fhdah S Alanazi, Hamad M Alkahtani, Alaa A-M Abdel-Aziz, et al.
RSC Advances
|
January 7, 2025
Remarkable utilization of quinazoline-based homosulfonamide for <i>in vitro</i> cytotoxic effects with triple kinase inhibition activities: cell cycle analysis and molecular docking profile
Adel S El-Azab, Alaa A-M Abdel-Aziz, Ahmed H Bakheit, et al.
Bioorganic Chemistry
|
November 4, 2020
Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysis
Adel S El-Azab, Alaa A-M Abdel-Aziz, Nawaf A AlSaif, et al.
European Journal of Medicinal Chemistry
|
January 1, 2015
Structure-based design of phthalimide derivatives as potential cyclooxygenase-2 (COX-2) inhibitors: anti-inflammatory and analgesic activities
Amer M Alanazi, Adel S El-Azab, Ibrahim A Al-Suwaidan, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 108) with videos related to
Sort By:
Page
of 11
Molecules (Basel, Switzerland)
|
February 25, 2023
A Liquid Chromatography Tandem Mass Spectrometry Method for the Simultaneous Estimation of the Dopamine Receptor Antagonist LE300 and Its N-methyl Metabolite in Plasma: Application to a Pharmacokinetic Study
Mohamed M Hefnawy, Mohamed W Attwa, Adeeba A Alzamil, et al.
European Journal of Medicinal Chemistry
|
October 17, 2016
Thiadiazolodiazepine analogues as a new class of neuromuscular blocking agents: Synthesis, biological evaluation and molecular modeling study
Hussein I El-Subbagh, Adel S El-Azab, Ghada S Hassan, et al.
Bioorganic & Medicinal Chemistry
|
June 27, 2016
Design, synthesis of 2,3-disubstitued 4(3H)-quinazolinone derivatives as anti-inflammatory and analgesic agents: COX-1/2 inhibitory activities and molecular docking studies
Alaa A-M Abdel-Aziz, Laila A Abou-Zeid, Kamal Eldin H ElTahir, et al.
European Journal of Medicinal Chemistry
|
June 19, 2016
Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones
Alaa A-M Abdel-Aziz, Laila A Abou-Zeid, Kamal Eldin H ElTahir, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
December 19, 2017
Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study
Magda A-A El-Sayed, Walaa M El-Husseiny, Naglaa I Abdel-Aziz, et al.
European Journal of Medicinal Chemistry
|
September 15, 2018
Structural alterations based on naproxen scaffold: Synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking
Walaa M El-Husseiny, Magda A-A El-Sayed, Naglaa I Abdel-Aziz, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 26, 2025
Synthesis, Antitumor Activities, and Apoptosis-Inducing Activities of Schiff's Bases Incorporating Imidazolidine-2,4-dione Scaffold: Molecular Docking Studies and Enzymatic Inhibition Activities
Fhdah S Alanazi, Hamad M Alkahtani, Alaa A-M Abdel-Aziz, et al.
RSC Advances
|
January 7, 2025
Remarkable utilization of quinazoline-based homosulfonamide for <i>in vitro</i> cytotoxic effects with triple kinase inhibition activities: cell cycle analysis and molecular docking profile
Adel S El-Azab, Alaa A-M Abdel-Aziz, Ahmed H Bakheit, et al.
Bioorganic Chemistry
|
November 4, 2020
Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysis
Adel S El-Azab, Alaa A-M Abdel-Aziz, Nawaf A AlSaif, et al.
European Journal of Medicinal Chemistry
|
January 1, 2015
Structure-based design of phthalimide derivatives as potential cyclooxygenase-2 (COX-2) inhibitors: anti-inflammatory and analgesic activities
Amer M Alanazi, Adel S El-Azab, Ibrahim A Al-Suwaidan, et al.
Page
of 11